The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...

The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

Multiple states have reached a tentative new agreement with the Sackler family, who made billions of dollars marketing OxyContin, the drug that set off the U.S. opioid crisis. New York State Attorney ...

Walgreens has long been a leader in providing education and resources, as well as implementing best-in-class policies and procedures, to help combat opioid misuse and abuse." Walgreens added that ...

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) saw its share prices on Friday drop by 3.17 percent to close at $12.52 apiece as investor sentiment was weighed down by news that it was slapped with a ...

The Department of Justice sued Walgreens Boots Alliance Inc. for allegedly dispensing opioids and other controlled substances at pharmacies across the US while ignoring red flags that the ...

UCLA, which was next to evacuation warning and mandatory evacuation zones, will reopen for in-person classes on Tuesday. UCLA had switched to remote instruction last week out of caution.

Delhi Government mandates hybrid learning for Classes IX and XI in its schools, as part of measures to tackle poor air quality. Schools under DOE, NDMC, MCD, and the Delhi Cantonment Board are ...

The Biden administration Wednesday finalized a long-awaited rule laying out how some health care providers can prescribe gold-standard opioid use disorder treatments through telehealth.